IL-1β further amplifies vascular inflammation through NF-κB and MAPK signaling, leading to increased secretion of IL-6, MCP-1, and endothelin-1, which collectively contribute to endothelial dysfunction and vascular remodeling in PAH (Agrawal et al., 2023). Here, NFKB1 is linked to pulmonary arterial hypertension.